Rituximab as a first-line therapy in children with new-onset idiopathic nephrotic syndrome.
Zhang X, Jin Y, Liu F, Li Q, Xie Y, Huang G, Chen J, He X, He S, Fu H, Wang J, Shen H, Mao J.
Zhang X, et al. Among authors: jin y.
Clin Kidney J. 2024 Nov 18;18(1):sfae348. doi: 10.1093/ckj/sfae348. eCollection 2025 Jan.
Clin Kidney J. 2024.
PMID: 39811259
Free PMC article.